Reduced DRD2 signaling in the hypothalamus is known to increase food intake, body weight, and regulate glucose metabolism (Ikeda et al., 2020), suggesting that the reduced DRD2 signaling may also be related to SCZ-related metabolic disorders such as increased BMI and abnormalities in glucose metabolism. This evidence concerns the gene DRD2 and metabolic disease.